This Article Full Text Full Text (PDF) All Versions of this Article: 93/4/1426    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maret, A. Articles by Levine, M. A. Search for Related Content PubMed PubMed Citation Articles by Maret, A. Articles by Levine, M. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Related Collections Calcium and Bone Metabolism

Analysis of the GCM2 Gene in Isolated Hypoparathyroidism: A Molecular and Biochemical Study

Division of Pediatric Endocrinology (A.M.), University Hospital of Geneva, CH-1211 Geneva, Switzerland; Division of Pediatrics and Department of Biomedical Engineering (C.D., M.A.L.), Lerner Research Institute and the Children’s Hospital, Cleveland Clinic, Cleveland, Ohio 44195; and Department of Psychology (S.L.K.), Drexel University, Philadelphia, Pennsylvania 19104

Address all correspondence and requests for reprints to: Michael A. Levine, M.D., The Children’s Hospital of Philadelphia, Division of Endocrinology, 34th Street and Civic Center Boulevard, Philadelphia, Pennsylvania 19104. E-mail: levinem{at}email.chop.edu.

Context: Hypoparathyroidism is characterized by hypocalcemia, hyperphosphatemia, and absent or markedly reduced serum levels of intact PTH. The transcription factor GCM2 is critical for the development of parathyroid glands in mice and humans.

Objective: We sought to determine the prevalence of GCM2 gene mutations in patients with familial or sporadic forms of isolated hypoparathyroidism (IH).

Design and Setting: We used PCR to analyze the promoter, the exons, and flanking intronic sequences in 10 IH families with 17 affected members and in 10 patients with sporadic IH. Wild-type and mutant GCM2 proteins were expressed in HEK293 cells and characterized.

Results: We identified nine single nucleotide changes, three in the 5' untranslated region and six in exon 5, that led to nonsynonymous changes in the GCM2 protein (G203S, I227V, Y282D, N315D, Q330L, and M354V). Variant GCM2 proteins had normal size, nuclear localization, and transactivational function when expressed in HEK293 cells. Similar analyses of two previously described GCM2 missense mutations, R47L and G63S, revealed decreased nuclear expression and markedly reduced (5–20% of normal) transactivational activity. The variant alleles did not segregate with inheritance of IH, and many of the single nucleotide substitutions were present in DNA from unrelated normal subjects, suggesting that these base changes were polymorphisms.

Conclusion: Our study describes nine single nucleotide changes in the GCM2 gene that represent polymorphisms. Although GCM2 mutations appear to be an uncommon cause of IH, the wide variety of GCM2 polymorphisms suggests that variant alleles may have a role in determining parathyroid function.

This article has been cited by other articles:

				M. Mannstadt, G. Bertrand, M. Muresan, G. Weryha, B. Leheup, S. R. Pulusani, B. Grandchamp, H. Juppner, and C. Silve Dominant-Negative GCMB Mutations Cause an Autosomal Dominant Form of Hypoparathyroidism J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3568 - 3576. [Abstract] [Full Text] [PDF]